Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miranda D Grounds

Showing results (11-20 of 121) with videos related to

Pageof 13
Sort By:
Neurobiology of Disease|June 27, 2006
Cromolyn administration (to block mast cell degranulation) reduces necrosis of dystrophic muscle in mdx miceHannah G Radley, Miranda D Grounds
Neuromuscular Disorders : NMD|February 20, 2007
The allure of stem cell therapy for muscular dystrophyMiranda D Grounds, Kay E Davies
Cell|December 28, 2006
Treating muscular dystrophy with stem cells?Kay E Davies, Miranda D Grounds
Cell Stem Cell|March 29, 2008
Modified patient stem cells as prelude to autologous treatment of muscular dystrophyKay E Davies, Miranda D Grounds
Cytotechnology|November 13, 2008
Harnessing the therapeutic potential of myogenic stem cellsJason D White, Miranda D Grounds
Biogerontology|December 25, 2009
Delayed but excellent myogenic stem cell response of regenerating geriatric skeletal muscles in miceThea Shavlakadze, John McGeachie, Miranda D Grounds
Current Topics in Developmental Biology|February 12, 2014
Skeletal muscle degeneration and regeneration in mice and fliesMamta Rai, Upendra Nongthomba, Miranda D Grounds
IUBMB Life|March 4, 2006
Muscle-derived stem cells: implications for effective myoblast transfer therapyTracey F Lee-Pullen, Miranda D Grounds
Current Opinion in Clinical Nutrition and Metabolic Care|June 11, 2008
Oxidative stress as a therapeutic target during muscle wasting: considering the complex interactionsPeter G Arthur, Miranda D Grounds, Thea Shavlakadze
Cell Calcium|June 13, 2006
Measurement of sub-membrane [Ca2+] in adult myofibers and cytosolic [Ca2+] in myotubes from normal and mdx mice using the Ca2+ indicator FFP-18Renzhi Han, Miranda D Grounds, Anthony J Bakker
Pageof 13

Showing results (11-20 of 121) with videos related to

Sort By:
Pageof 13
Neurobiology of Disease|June 27, 2006
Cromolyn administration (to block mast cell degranulation) reduces necrosis of dystrophic muscle in mdx miceHannah G Radley, Miranda D Grounds
Neuromuscular Disorders : NMD|February 20, 2007
The allure of stem cell therapy for muscular dystrophyMiranda D Grounds, Kay E Davies
Cell|December 28, 2006
Treating muscular dystrophy with stem cells?Kay E Davies, Miranda D Grounds
Cell Stem Cell|March 29, 2008
Modified patient stem cells as prelude to autologous treatment of muscular dystrophyKay E Davies, Miranda D Grounds
Cytotechnology|November 13, 2008
Harnessing the therapeutic potential of myogenic stem cellsJason D White, Miranda D Grounds
Biogerontology|December 25, 2009
Delayed but excellent myogenic stem cell response of regenerating geriatric skeletal muscles in miceThea Shavlakadze, John McGeachie, Miranda D Grounds
Current Topics in Developmental Biology|February 12, 2014
Skeletal muscle degeneration and regeneration in mice and fliesMamta Rai, Upendra Nongthomba, Miranda D Grounds
IUBMB Life|March 4, 2006
Muscle-derived stem cells: implications for effective myoblast transfer therapyTracey F Lee-Pullen, Miranda D Grounds
Current Opinion in Clinical Nutrition and Metabolic Care|June 11, 2008
Oxidative stress as a therapeutic target during muscle wasting: considering the complex interactionsPeter G Arthur, Miranda D Grounds, Thea Shavlakadze
Cell Calcium|June 13, 2006
Measurement of sub-membrane [Ca2+] in adult myofibers and cytosolic [Ca2+] in myotubes from normal and mdx mice using the Ca2+ indicator FFP-18Renzhi Han, Miranda D Grounds, Anthony J Bakker
Pageof 13